Two Week Cross-Over Study Comparing Two Daily Disposable Contact Lenses
NCT ID: NCT01155323
Last Updated: 2018-06-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
118 participants
INTERVENTIONAL
2010-03-01
2010-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Comparison of Two Daily Disposable Contact Lenses.
NCT00775021
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
NCT02024698
1 Week Crossover Study Between Two Soft Contact Lenses
NCT06611410
Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear
NCT01669629
Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2
NCT04615507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
etafilcon A/omafilcon A
etafilcon A contact lenses will be worn during the first week and omafilcon A contact lenses will be worn during the second. Lenses were replaced daily
etafilcon A
1-day soft contact lens
omafilcon A
1-day soft contact lens
omafilcon A/etafilcon A
omafilcon A contact lenses will be worn during the first week and etafilcon A contact lenses will be worn during the second. Lenses were replaced daily.
etafilcon A
1-day soft contact lens
omafilcon A
1-day soft contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
etafilcon A
1-day soft contact lens
omafilcon A
1-day soft contact lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Existing soft contact lens wearers
* Willing to signed a written Informed Consent.
* Own a mobile phone and are willing to receive and reply to Short Message Service (SMS) messages during the day.
* Have a contact lens spherical distance requirement between -1.00 diopters (D) and -6.00 diopters (D) in both eyes.
* Have an Astigmatism of 1.00D or less in both eyes.
* Require a visual correction in both eyes.
* Be correctable to a visual acuity of 6/9 (20/30) or better in each eye.
* Have normal eyes with no evidence of abnormality or disease that would preclude lens wear.
Exclusion Criteria
* Clinically significant corneal staining (Grade 3 in more than one region).
* Keratoconus or other corneal irregularity.
* Abnormal lachrymal secretions.
* Extended wear of contact lenses last 3 months.
* Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in the previous 8 weeks.
* Refractive surgery.
* Eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
* Pre-existing ocular irritation that would preclude contact lens fitting.
* Require concurrent ocular medication
* Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
* Any infectious disease (e.g., hepatitis, tuberculosis) or any immunosuppressive disease (e.g., HIV).
* Diabetes.
* Pregnant, lactating or planning a pregnancy at the time of enrollment.
* Participation in any concurrent clinical trial or in last 30 days.
18 Years
39 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson K.K. Medical Company
INDUSTRY
Visioncare Research Ltd.
OTHER
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danny Sim, Diploma in Optometry
Role: PRINCIPAL_INVESTIGATOR
Singapore Polytechnic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Singapore Plytechnic
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DISP-523
Identifier Type: OTHER
Identifier Source: secondary_id
CR-0926
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.